Back to Results
First PageMeta Content
Biotechnology / Abatacept / Disease-modifying antirheumatic drug / Etanercept / Biologic / Rheumatology / Rituximab / Eisai / Adalimumab / Pharmacology / Immunosuppressants / Medicine


Providing Affordable Treatment: Biosimilar Agents Dae Hyun Yoo, M.D. Rheumatology and Internal Medicine
Add to Reading List

Document Date: 2014-04-23 05:34:26


Open Document

File Size: 2,21 MB

Share Result on Facebook

Company

Pfizer / Eisai / Lilly / Sanofi / Aventis / /

Country

Korea / /

Currency

USD / /

Facility

Internal Medicine Hanyang University / /

MedicalCondition

Yes Yes Consider disease / /

Organization

Hanyang University / Seoul / /

Person

Dae Hyun Yoo / Ann Rheum Dis / /

Position

Scientific adviser / /

SocialTag